Articles tagged with Cancer Screening
Adult childhood cancer survivors experience elevated fear of cancer recurrence, emphasizing the importance of routine screening and timely symptom intervention. The study's findings suggest that fear of cancer recurrence should be a significant concern in survivorship care.
A retrospective cohort study found that AI algorithms can identify women at high risk of developing breast cancer 4-6 years before detection. The results suggest using commercial AI algorithms as a pathway to personalized screening approaches, leading to earlier cancer diagnosis.
A new study published in JAMA Network Open found that racial and ethnic minorities are more likely to have claims for free preventive care denied by insurance plans, leading to unexpected bills or lack of access. Healthcare providers also charge disadvantaged groups a higher amount for preventive services.
A new study found significant disparities in at-home test use among older adults, with those having a college degree or higher and higher incomes being more likely to use them. However, Black older adults were less likely to use these tests compared to other racial/ethnic groups.
A new study aims to increase follow-up care for patients who receive abnormal stool-based fecal immunochemical tests, focusing on improving coordination between primary and specialty clinics. The goal is to improve colorectal cancer screening processes in underserved populations, increasing survival and reducing mortality.
Researchers propose reevaluating nomenclature for low-grade prostate cancer, a condition that rarely metastasizes or causes symptoms. This shift aims to balance detection with treatment to reduce harms of overdiagnosis and overtreatment.
Researchers seek to identify Hispanic women at risk of developing chronic diseases through early screenings or interventions, aiming to improve health outcomes for millions in the population.
According to the Global Cancer Observatory (GLOBOCAN), lung cancer is the most common type of cancer, with 2.2 million new cases and 1.8 million deaths worldwide in 2020. China had the highest number of new cases, and incidence and mortality rates have been steadily rising from 1990 to 2019.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center developed a biobank of 294 samples from 126 patients with 25 different subtypes of bone and soft tissue sarcoma. The team created tumor organoids that retained key characteristics of the original tumors, which were then subjected to high-throughput drug screening. They iden...
A 10-year study found that digital breast tomosynthesis increases cancer detection rates and reduces advanced cancers compared to conventional 2D digital mammography. DBT detected more aggressive cancers at an earlier stage than digital mammography, leading to improved cancer detection and lower recall rates.
A new study published in Radiology journal reveals that advanced 3D mammography detects breast cancer earlier and less often results in false positives compared to traditional digital mammography. This improved detection rate has significant implications for breast cancer diagnosis and treatment.
Researchers found that humorous comic strip cartoons increased likelihood of agreeing to take a quiz on personal risk for colon cancer. Exposing people to funny content reduced information avoidance, making them more likely to choose to watch a video about colorectal cancer prevention.
The COVID-19 pandemic has led to a decrease in cancer diagnosis rates in the US, according to a new study. Despite improved trends in 2021, the rates remain lower than expected, exacerbating the existing deficit of diagnosed cases from 2020.
Generative AI is revolutionizing oncological imaging by expanding datasets and improving image quality. This technology enables predictive oncology and personalized cancer screening, offering new hope in the fight against cancer.
Researchers have developed an integrated optical sensor capable of detecting dopamine directly from unprocessed blood samples. This breakthrough enables low-cost and efficient screening tools for various neurological conditions and cancers.
A Mayo Clinic study found that people with monoclonal B-cell lymphocytosis (MBL) have a 92% elevated risk of developing melanoma. MBL is a precursor to chronic lymphocytic leukemia and also increases the risk of cancers originating in the lymphatic system and serious infections.
A large cohort study found that false-positive mammography results lead to a significant decrease in subsequent screening rates among women. The study, published in Annals of Internal Medicine, highlights the potential unintended consequence of false positives on routine breast cancer screening participation.
Researchers have developed a nanodrug that targets miR-10b, a small noncoding RNA implicated in cancer cell invasion and proliferation. The study shows that inhibiting miR-10b reduces the stemness of breast cancer cells, supporting dedifferentiation as a potential therapeutic mechanism.
Women with regular annual mammograms had higher overall survival and lower late-stage cancer rates than those screened less frequently. The study's findings contradict current guidelines, suggesting a significant benefit to annual screening for women over 40.
Researchers explore AI's role in addressing challenges in immunotherapy, developing new biomarkers for precise disease characterization and predicting treatment response. A comprehensive review applied AI/radiomics to cross-sectional imaging, showcasing the current landscape in IO treatment.
Researchers found that CHEK2 variants do not increase colorectal cancer risk compared to controls. Three low-risk missense variants were identified as potential drivers of breast cancer risk variability.
Researchers used low-cost videoscopes to create high-quality 'oral selfies' for OPSCC screening, demonstrating their feasibility and effectiveness. The study's findings support the potential of these devices as a viable tool for widespread screening in resource-limited settings.
The field of cancer immunotherapy is advancing with innovations in precision medicine, including adoptive cell transfer therapy, TCR-engineered T cells, and natural killer cell therapy. Therapeutic vaccines are also being developed to target specific cancer antigens, offering new treatment options for patients.
Esophageal cancer is a major public health concern in China, with late diagnoses contributing to poor prognosis. Early detection through screening methods like endoscopy and biomarker detection has shown significant outcomes, particularly in high-risk areas.
The study analyzes six major digestive system cancers worldwide and in China, revealing correlations between country HDI and cancer prevalence. Colorectal cancer is the most prevalent, while Asia accounts for 60.5% of new gastrointestinal cancer cases globally.
The review explores the progression of oral leukoplakia to oral squamous cell carcinoma, highlighting genetic and epigenomic alterations, as well as sample collection methods for research and diagnosis. Advances in sequencing technologies and single-cell analyses are providing deeper insights into cancer progression.
Recent advances highlight PIK3CA mutation significance in determining targeted therapy efficacy, particularly in advanced breast cancer. Molecular signatures and genetic profiles drive personalized treatment strategies, with emerging therapies offering new hope for patients.
Early oral cancer detection improves patient outcomes and reduces mortality. Advanced technologies like imaging and AI enhance the accuracy of traditional screening methods.
A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.
A recent study published in Radiology found that solid lung nodules were present in approximately 42% of non-smoking adults, with prevalence increasing with age. The study suggests that current nodule follow-up guidelines may lead to unnecessary follow-up examinations for low-risk individuals.
A global study predicts significant increases in cancer cases and deaths among men between 2022 and 2050, with widening disparities by age and country's economic status. Disparities are projected to worsen, with poorer survival rates observed among older men and those living in low-human development index countries.
This systematic review examines current methodologies and updates in early diagnosis practices for HNSCC, highlighting the need for effective screening methods. Effective early diagnostic practices will significantly impact patient outcomes, reducing the burden of HNSCC and enhancing quality of life.
EZH2 plays a multifaceted role in cancer biology, influencing both tumor and immune cells. Its inhibition has shown synergistic effects with various immunotherapies, offering new avenues for treating resistant cancers. Ongoing research aims to elucidate the mechanisms of EZH2 modulation and develop targeted inhibitors.
A research team has identified novel biomarkers in cervical mucus samples that show high diagnostic power for detecting cervical cancer. The findings suggest that analyzing local expression levels may offer a superior diagnostic strategy, potentially reducing the need for invasive procedures.
Recent studies from Asia indicate that low-radiation dose computed tomography screening is more effective in detecting cancers in those with a family history of lung cancer, but the benefits are uncertain for never-smokers. The authors advocate for more rigorous research to understand the benefits and harms of screening this population.
Researchers highlight acute need for mental health services and support for men with prostate cancer. The study found that 15% of prostate cancer patients started anti-anxiety and antidepression medications at diagnosis, while only 6% sought help from mental health services.
Researchers identified areas with lower colorectal cancer screening rates and developed an interactive web map to pinpoint neighborhood-level disparities. The study aims to inform targeted education or intervention programs, ultimately increasing screening rates in priority neighborhoods and contributing to national improvements.
A balanced diet rich in fruits, vegetables, whole grains, and legumes can lower cancer risk by repairing cells and reducing inflammation. Further research is necessary to clarify the relationships between diet, supplements, and cancer prevention.
A study published in PLOS Medicine found that abnormal routine blood test results can predict cancer risk in patients with abdominal symptoms. The researchers analyzed data from over 470,000 patients and identified specific blood abnormalities linked to increased cancer risk across different age groups and sex.
The review highlights the controversy surrounding asbestos-related research and the varying results on its carcinogenicity. It emphasizes the need for high-quality, independent studies to resolve existing debates and inform public health policies.
A recent review article highlights the importance of genetic testing for men carrying BRCA1 or BRCA2 mutations, which increase their risk of developing prostate, pancreatic, and breast cancers. The guidelines emphasize the need for personalized cancer screening to help identify high-risk individuals.
Cervical cancer is a significant global health issue, with over 443,000 deaths annually projected by 2030. Widespread HPV vaccination and regular screening are crucial in preventing infections and early detection of abnormalities.
A new study published in JAMA Network Open shows that an at-home fecal immunochemical testing (FIT) screen can reduce the risk of colorectal cancer death by 33%, comparable to screening colonoscopy. FIT is a non-invasive test that involves mailing a stool sample to the laboratory for analysis.
Researchers found that eliminating racial disparities in follow-up colonoscopy rates and quality would significantly reduce colorectal cancer incidence and mortality. By closing these gaps, the study aims to achieve health equity and find innovative solutions for true change.
Researchers introduced a novel method for improving anti-cancer drug detection using advanced three-dimensional cell culture technology. The new platform enables more accurate assessment of chemotherapeutic agents by simulating physiological conditions that cancer cells encounter in the body.
A nested case-control study found that completing fecal immunochemical tests lowers overall death risk from colorectal cancer, particularly in the left colon. The association was observed across racial and ethnic groups, supporting its use in population-based screening strategies.
A Mayo Clinic study reveals that current genetic screening protocols fail to detect notable numbers of people carrying hereditary breast and ovarian cancer syndrome and Lynch syndrome mutations. The study identified 550 carriers of these mutations, with half being previously unaware of their risk.
A study of nearly half a million women found that endometriosis was associated with a higher risk of ovarian cancer. The risk was particularly elevated among women with ovarian endometriomas or deep infiltrating endometriosis, with a 19-fold increased risk for certain types of ovarian cancer.
A nationally representative US survey found that women aged 39-49 who received a decision aid describing the benefits and harms of breast cancer screening were more likely to delay or forego screening. The study suggests that providing accurate information may change intention to screen for some women, particularly those with higher br...
Researchers found that out-of-pocket costs for additional tests, including MRI and biopsies, are common and increasing among privately insured men with high PSA results. The median cost rose substantially between 2010-2020, deterring patients from undergoing recommended screening.
A new urine-based test accurately measures high-risk HPV16 E7 oncoproteins in urine to detect cervical cancer. The test shows promise in making cervical cancer screening more accessible and less invasive.
A cross-sectional study found that e-cigarette users were less likely to undergo lung cancer screening. The research suggests that e-cigarettes contain carcinogens and may cause similar gene deregulations as combustible tobacco. This association may be particularly concerning for individuals who have quit smoking combustible cigarettes.
A recent study published in JAMA found that transgender women on hormone therapy have drastically lower PSA levels, which may lead to delayed diagnosis and treatment of prostate cancer. The researchers analyzed Veterans Health Administration records and recommended caution when interpreting PSA values in transgender women.
A new study from the University of Copenhagen reveals that AI has helped detect significantly more cases of breast cancer and reduce radiologist workloads. The AI system has been used to analyze tens of thousands of X-rays every year, resulting in a 12% increase in detected cases, including more small tumours of one centimetre or less.
Current prostate cancer screening guidelines may not be effective for transgender women taking estrogen, as it can lower PSA levels, making it difficult to detect early-stage cancer. The study aims to provide more appropriate screening guidelines for this population.
The special issue explores challenges and opportunities in managing synthetic genomics risks, introducing a common global baseline for nucleic acid synthesis screening. Review articles provide insights into enhancing gene synthesis security and biosecurity practices of synthetic DNA providers.
Xiaohu Xia's research focuses on enhancing diagnostic efficacy of enzyme-linked immunosorbent assay (ELISA) testing using specially tailored nickel-platinum nanoparticles. His goal is to improve disease detection accuracy by more than 300 times, enabling early diagnosis of cancers like prostate and colorectal cancer.
St. Jude researchers found that early surveillance after genetic predisposition discovery detects new, treatable tumors in 70% of cases. This approach can avoid chemotherapy and radiation, improving outcomes for children with cancer.
Gender diverse individuals face barriers in accessing healthcare screening, leading to a higher risk of undetected cancer. Nurse practitioners can play a crucial role in closing this gap by providing culturally safe care and promoting regular screenings.
Human papillomavirus (HPV) is a major cause of several cancers, with cervical cancer being the most prominent. Persistent infection with high-risk HPV types can lead to malignant transformation. Vaccination and screening programs are crucial in preventing HPV-related cancers.